We used GEPIA to compare ZnT1 levels in 30 cancer types and their cognate healthy tissues (all cancers are available in GEPIA excluding Pheochromocytoma and Paraganglioma that did not have sufficient control samples for ZnT1). This evidence concerns the gene SLC30A1 and hereditary pheochromocytoma-paraganglioma.